Insider Stock Trading History of Forbes William P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Forbes William P since year 2005. The trader's CIK number is 1314760. At the time of this reporting, Forbes William P is the President, Medical R&D and CDO of Salix Pharmaceuticals Ltd . (stock ticker symbol SLXP). See this page for all insider trading activities at Salix Pharmaceuticals Ltd .


Stock purchases, sales, and option exercises reported by insider Forbes William P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-03-09 SLXP Salix Pharmaceuticals Ltd Sale 42,880 157.84 6,768,179
2015-03-06 SLXP Salix Pharmaceuticals Ltd Sale 20,000 157.96 3,159,200
2014-11-12 SLXP Salix Pharmaceuticals Ltd Option Ex 17,450 17.58 306,770
2014-11-12 SLXP Salix Pharmaceuticals Ltd Sale 11,079 95.05 1,053,058
2014-01-08 SLXP Salix Pharmaceuticals Ltd Option Ex 8,000 17.53 140,240
2014-01-08 SLXP Salix Pharmaceuticals Ltd Sale 8,000 90.06 720,480
2013-07-24 SLXP Salix Pharmaceuticals Ltd Sale 12,000 70.92 851,004
2013-07-24 SLXP Salix Pharmaceuticals Ltd Option Ex 12,000 17.53 210,360
2013-04-10 SLXP Salix Pharmaceuticals Ltd Option Ex 13,000 17.53 227,890
2013-04-10 SLXP Salix Pharmaceuticals Ltd Sale 8,673 49.37 428,186
2012-05-08 SLXP Salix Pharmaceuticals Ltd Sale 10,000 51.80 518,050
2012-05-08 SLXP Salix Pharmaceuticals Ltd Option Ex 10,000 17.53 175,300
2012-02-13 SLXP Salix Pharmaceuticals Ltd Option Ex 4,297 17.53 75,326
2012-02-13 SLXP Salix Pharmaceuticals Ltd Sale 4,297 50.00 214,850
2012-02-03 SLXP Salix Pharmaceuticals Ltd Option Ex 259 17.53 4,540
2012-02-03 SLXP Salix Pharmaceuticals Ltd Sale 259 50.00 12,950
2012-01-17 SLXP Salix Pharmaceuticals Ltd Option Ex 1,119 17.53 19,616
2012-01-18 SLXP Salix Pharmaceuticals Ltd Option Ex 125 17.53 2,191
2012-01-17 SLXP Salix Pharmaceuticals Ltd Sale 1,119 50.06 56,016
2012-01-18 SLXP Salix Pharmaceuticals Ltd Sale 125 50.00 6,250
2011-07-07 SLXP Salix Pharmaceuticals Ltd Sale 13,000 39.60 514,761
2011-05-16 SLXP Salix Pharmaceuticals Ltd Option Ex 20,000 17.53 350,600
2011-05-16 SLXP Salix Pharmaceuticals Ltd Sale 20,000 40.35 806,979
2010-11-10 SLXP Salix Pharmaceuticals Ltd Option Ex 10,000 17.53 175,300
2010-11-10 SLXP Salix Pharmaceuticals Ltd Sale 10,000 40.00 400,050
2010-09-15 SLXP Salix Pharmaceuticals Ltd Sale 10,695 40.50 433,104
2010-04-14 SLXP Salix Pharmaceuticals Ltd Option Ex 10,000 17.53 175,300
2010-04-14 SLXP Salix Pharmaceuticals Ltd Sale 10,000 40.02 400,250
2010-04-01 SLXP Salix Pharmaceuticals Ltd Sale 1,879 38.00 71,402
2009-12-23 SLXP Salix Pharmaceuticals Ltd Sale 5,000 25.00 125,000
2007-07-03 SLXP Salix Pharmaceuticals Ltd Sale 1,113 12.32 13,712

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Forbes William P (President, Medical R&D and CDO of Salix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.